[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @asininitybeyond asininityandbeyond asininityandbeyond posts on X about $nvs, novartis, cash flow, $20b the most. They currently have XXX followers and X posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::973806872171024385/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +124% - X Months XXXXXXX +0.03% - X Year XXXXXXX +106% ### Mentions: X [#](/creator/twitter::973806872171024385/posts_active)  - X Week X -XX% - X Month XX +11% - X Months XX -XX% - X Year XXX +74% ### Followers: XXX [#](/creator/twitter::973806872171024385/followers)  - X Week XXX +0.99% - X Month XXX +4.90% - X Months XXX +13% - X Year XXX +32% ### CreatorRank: XXXXXXX [#](/creator/twitter::973806872171024385/influencer_rank)  ### Social Influence [#](/creator/twitter::973806872171024385/influence) --- **Social category influence** [stocks](/list/stocks) XX% [finance](/list/finance) XXXX% **Social topic influence** [$nvs](/topic/$nvs) 12.5%, [novartis](/topic/novartis) 12.5%, [cash flow](/topic/cash-flow) 12.5%, [$20b](/topic/$20b) 12.5%, [$12b](/topic/$12b) 12.5%, [dual](/topic/dual) 12.5%, [$lly](/topic/$lly) XXXX% **Top accounts mentioned or mentioned by** [@tom_the_bomb__](/creator/undefined) [@tomthebomb](/creator/undefined) [@rah00084](/creator/undefined) [@avacta](/creator/undefined) [@bobdibble8](/creator/undefined) [@towlie1981](/creator/undefined) [@pjcrabb](/creator/undefined) [@rugby7170](/creator/undefined) [@ruthyrururu](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/$nvs) [Eli Lilly and Company (LLY)](/topic/$lly) ### Top Social Posts [#](/creator/twitter::973806872171024385/posts) --- Top posts by engagements in the last XX hours "For those who like $NVS for #AVCT Novartis CEO says it has the firepower for big M&A deals: 'Can never be done' free cash flow is approaching $20b a year so have adequate firepower to do deals like this Avidity for $12b + to bolster growth profile"" [X Link](https://x.com/asininitybeyond/status/1983448071150416062) [@asininitybeyond](/creator/x/asininitybeyond) 2025-10-29T08:17Z XXX followers, 5169 engagements "Worth a read as #AVCT prepares for #AACR ADCs seemingly dominated ESMO. What we're seeing now is we're getting much more precision with the targets much more precision with the linker and payload combinations - GSK Something Avacta has perfected.1/2" [X Link](https://x.com/asininitybeyond/status/1980535407113900387) [@asininitybeyond](/creator/x/asininitybeyond) 2025-10-21T07:23Z XXX followers, 2383 engagements "@tom_the_bomb__ @BobDibble8 @avacta This is it exactly IMO FAP-Dox has proven the platform for #AVCT EXd is seemingly on everyones wish list; so catering to that via 6103 With some of the inhibitors in the dual payload drugs + MMAE we are targeting the audience more. You then have $LLY with the IP via Point 1/3" [X Link](https://x.com/asininitybeyond/status/1983506707666927907) [@asininitybeyond](/creator/x/asininitybeyond) 2025-10-29T12:10Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@asininitybeyond asininityandbeyond
asininityandbeyond posts on X about $nvs, novartis, cash flow, $20b the most. They currently have XXX followers and X posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XX%
- X Month XXXXXX +124%
- X Months XXXXXXX +0.03%
- X Year XXXXXXX +106%
Mentions: X #
- X Week X -XX%
- X Month XX +11%
- X Months XX -XX%
- X Year XXX +74%
Followers: XXX #
- X Week XXX +0.99%
- X Month XXX +4.90%
- X Months XXX +13%
- X Year XXX +32%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XX% finance XXXX%
Social topic influence $nvs 12.5%, novartis 12.5%, cash flow 12.5%, $20b 12.5%, $12b 12.5%, dual 12.5%, $lly XXXX%
Top accounts mentioned or mentioned by @tom_the_bomb__ @tomthebomb @rah00084 @avacta @bobdibble8 @towlie1981 @pjcrabb @rugby7170 @ruthyrururu
Top assets mentioned Novartis AG (NVS) Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"For those who like $NVS for #AVCT Novartis CEO says it has the firepower for big M&A deals: 'Can never be done' free cash flow is approaching $20b a year so have adequate firepower to do deals like this Avidity for $12b + to bolster growth profile""
X Link @asininitybeyond 2025-10-29T08:17Z XXX followers, 5169 engagements
"Worth a read as #AVCT prepares for #AACR ADCs seemingly dominated ESMO. What we're seeing now is we're getting much more precision with the targets much more precision with the linker and payload combinations - GSK Something Avacta has perfected.1/2"
X Link @asininitybeyond 2025-10-21T07:23Z XXX followers, 2383 engagements
"@tom_the_bomb__ @BobDibble8 @avacta This is it exactly IMO FAP-Dox has proven the platform for #AVCT EXd is seemingly on everyones wish list; so catering to that via 6103 With some of the inhibitors in the dual payload drugs + MMAE we are targeting the audience more. You then have $LLY with the IP via Point 1/3"
X Link @asininitybeyond 2025-10-29T12:10Z XXX followers, XXX engagements